Biologic Drug Substance And Drug Product Preferred Provider Use
Source: ISR Reports
In Q4, 2018 ISR asked 124 outsourcers of biologic drug substance and 138 outsourcers of biologic drug product about their organizations’ use of preferred providers. The data show the majority of respondents from both categories work at companies that use a preferred provider approach to outsourcing, and average about four CMOs on their lists.
access the Infographic!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online
ISR Reports
This website uses cookies to ensure you get the best experience on our website. Learn more